(2R,3R,4S,5S,6R)-2-[[(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

CC[C@H](CC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C)C)C(C)C

InChI=1S/C35H60O6/c1-7-22(20(2)3)9-8-21(4)26-12-13-27-25-11-10-23-18-24(14-16-34(23,5)28(25)15-17-35(26,27)6)40-33-32(39)31(38)30(37)29(19-36)41-33/h10,20-22,24-33,36-39H,7-9,11-19H2,1-6H3/t21-,22-,24+,25+,26-,27+,28+,29-,30-,31+,32-,33-,34+,35-/m1/s1

NPJICTMALKLTFW-OFUAXYCQSA-N

Daucosterol; Sitogluside; 474-58-8; Eleutheroside A; Alexandrin; Daucosterin; Coriandrinol; beta-Sitosterol glucoside; BSSG; Sitoglusidum; Doursterol; Sterolin; WA 184; Daucosterine; EU-4906; beta-Daucosterol; AW 10; Eleutheroside A; NSC-165962; BSS-G; Sitogluside (USAN/INN); 3-beta-(beta-D-Glucopyranosyloxy)stigmast-5-ene; beta-sitosteryl-beta-D-glucopyranoside; .beta.-sitosterol-glucoside; CHEMBL506678; CHEBI:67554; Sitosterol-3-O-beta-D-glucoside; AW-10; U45VN859W3; (3beta)-stigmast-5-en-3-yl beta-D-glucopyranoside; WA-184; .beta.-D-Glucopyranoside, (3.beta.)-stigmast-5-en-3-yl; beta-sitosterol 3-O-beta-D-glucopyranoside; (-)-beta-Sitosterol-beta-D-glucopyranoside; D05848; (2R,3R,4S,5S,6R)-2-[[(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol; Sitoglusido; NSC165962; Sitosteryl glycoside; sitosterol glucuronide; Sitosterol D-glucoside; beta-Sitosteryl glucoside; AC1NX3NW; beta-sitosterol glucutonide; Sitogluside [USAN:INN]; Sitoglusidum [INN-Latin]; Sitoglusido [INN-Spanish]; beta-Sitosterol beta-D-Glucoside; beta-Sitosterol monoglucoside; UNII-U45VN859W3; beta-sitosterol-beta-D-glycoside; FT-0686600; CID5742590; NSC 165962; EU 4906; BRN 4359450; SITOGLUSIDE [INN]; O-glucosyl-beta-sitosterol; SITOGLUSIDE [USAN]; SureCN137210; 3beta-(beta-D-Glucopyranosyloxy)stigmast-5-ene; b-Sitosterol b-D-glucoside; beta-Sitosterol D-glucoside; Ambap474-58-8; C011015; SCHEMBL137210; sitosteryl 3-beta-D-glucoside; (3-beta)-Stigmast-5-en-3-yl-beta-D-glucopyranoside; DTXSID301045674; HY-N0410; 3-O-beta-D-glucosyl-beta-sitosterol; BDBM50257635; MFCD01683621; ZINC49888788; beta-sitosterol 3-O-beta-D-glucoside; beta-sitosterol-beta-D-glucopyranoside; AKOS032962016; CS-5421; .BETA.-SITOSTEROL-.BETA.-D-GLUCOSIDE; C20785; SITOSTEROL 3-O-.BETA.-D-GLUCOPYRANOSIDE; 474D588; Q-100502; Stigmast-5-ene, 3-beta-(beta-D-glucopyranosyloxy)-; beta-D-Glucopyranoside, (3beta)-stigmast-5-en-3-yl; Q15410900; 3.BETA.-(.BETA.-D-GLUCOPYRANOSYLOXY)STIGMAST-5-ENE; BETA-SITOSTEROL GLUCOSIDE (DAUCOSTEROL) (CONSTITUENT OF STINGING NETTLE) [DSC]; (2R,3R,4S,5S,6R)-2-((3S,8S,9S,10R,13R,14S,17R)-17-((2R,5R)-5-ethyl-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yloxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; (2R,3R,4S,5S,6R)-2-[[(3S,8S,9S,10R,13R,14S,17R)-17-[(1R,4R)-4-ethyl-1,5-dimethyl-hexyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol